Robert Bona, MD, Named Director of Benign Hematology Program at Yale Cancer Center Smilow Cancer Hospital
Yale Cancer Center has announced the appointment of Robert Bona, MD, as Professor of Medicine (Hematology) and inaugural Director of the Benign Hematology Program at Smilow Cancer Hospital. He will also join as Medical Director of the Hemophilia Treatment Center for the Pediatric Hematology & Oncology Program at Smilow Cancer Hospital. Dr. Bona is a leader in the clinical care and research of benign hematologic conditions, having led several research studies, clinical trials, and care innovations to advance the treatment of blood diseases. Dr. Bona will start his new position on July 1.
Robert Bona, MD
Charles Fuchs, MD, MPH
Dr. Bona has been serving as a part-time member of the hematology department at Yale Cancer Center for the past 3 years. “We look forward to working more closely with Dr. Bona to build a comprehensive program for patients with inherited and acquired blood diseases,” said Charles Fuchs, MD, MPH, Director of Yale Cancer Center and Physician-in-Chief at Smilow Cancer Hospital.
Dr. Bona joins Yale from Quinnipiac University, where he is currently a founding faculty member and Professor of Medical Sciences at the Frank H. Netter MD School of Medicine. Previously, he served as Division Chief and Fellowship Program Director at the University of Connecticut School of Medicine. He also has strong ties to St. Francis Hospital and Medical Center, where he began his career after fellowship.